PPARG and Hypercholesterolemia: In an animal model of colorectal tumors and human familial adenomatous polyposis, referred to as APC-deficient mice, Niho and their colleagues found concomitant suppression of hypercholesterolemia and intestinal polyp formation by PPARγ ligands [54].